Shingles (Herpes Zoster): Symptoms, Course, and Key Features
Shingles results from reactivation of varicella-zoster virus (VZV) in a dorsal root ganglion. It follows a unilateral dermatomal distribution.
Classic Presentation
- Prodrome (1–5 days): Burning, stabbing, or throbbing pain ± itch, paresthesia, headache, photophobia, malaise.
- Eruptive phase: Erythematous maculopapular rash → grouped vesicles on erythematous base in a single dermatome (thoracic > trigeminal > lumbar).
- Vesicles pustulate → crust over 7–10 days. Healing in 2–4 weeks; may leave hyperpigmentation or scarring.
Key Features
- Dermatomal distribution: Does not cross midline (unlike disseminated zoster in immunocompromised).
- Allodynia/hyperesthesia: Light touch (clothing, breeze) causes severe pain.
- Associated symptoms: Fever, fatigue, headache, nausea.
Complications
- Postherpetic neuralgia (PHN): pain >90 days after rash onset (10–18% risk, ↑ with age)
- Herpes zoster ophthalmicus (V1): vision threat—urgent ophthalmology
- Ramsay Hunt syndrome (geniculate ganglion): facial palsy, ear pain, vesicles
- Bacterial superinfection, motor weakness, CNS involvement (rare)
Treatment
Antivirals (valacyclovir 1g TID × 7 days) within 72 hrs of rash onset reduce severity and PHN risk. Adjuncts: gabapentin/pregabalin, topical lidocaine, corticosteroids (controversial).
Prevention
Recombinant zoster vaccine (Shingrix) 2 doses ≥50 yrs or ≥19 immunocompromised—>90% efficacy.
Illness - Related Articles
- Safe Sharps Disposal in South Carolina: A Guide
- Bad Breath (Halitosis): 10 Effective Strategies for Fresh Breath
- Generalized Anxiety Disorder (GAD): Diagnosis and Treatment
- Limitations of Epidemiological Studies: Confounding, Bias, and Resource Constraints
- Monitoring IV Fluid Therapy: A Comprehensive Guide for Clinicians
- Spinal Meningitis Tests: Diagnosis & What to Expect
- Black Mold Exposure: Symptoms, Health Risks & What to Do
